Group 1: ETF Market Overview - The total scale of ETFs in Shanghai and Shenzhen has exceeded 4.3 trillion yuan, with Shanghai ETFs totaling over 3.14 trillion yuan and Shenzhen ETFs exceeding 1.15 trillion yuan, showing steady growth from the previous month [1] - The first batch of 10 Sci-Tech Innovation Bond ETFs was launched on July 17, attracting significant market attention and reshaping the market landscape for bond ETFs, which are becoming an important force in the secondary market [1] Group 2: A-Share Companies Going Public in Hong Kong - Ten A-share listed companies have successfully gone public in Hong Kong this year, raising approximately 70% of the total fundraising amount for new listings in the Hong Kong stock market [1] - A total of 78 A-share companies have either submitted applications to the Hong Kong Stock Exchange or announced plans to list in Hong Kong, covering various industries such as pharmaceuticals, power equipment, food and beverage, and finance [1] - The practice of issuing new shares at a discount in Hong Kong has been broken, with companies like CATL achieving premium issuance, marking a significant shift in the market [1] Group 3: A-Share Buyback Activity - The A-share buyback market remains active, with many companies announcing large buyback plans, primarily for employee stock ownership plans or equity incentive plans [2] - As of July 28, 688 A-share companies or significant shareholders have obtained buyback financing loans, totaling approximately 140.97 billion yuan [2] Group 4: Corporate Governance and Management Changes - Huizhou Intelligent announced the resignation of director Chen Youde due to being identified as a dishonest executor by the court [5] - Aojie Technology reported the resignation of two directors, with no impact on the normal operation of the board [6] - Shiming Technology disclosed that its actual controller and chairman, Lu Yong, has been placed under detention due to personal matters, but the company's operations remain unaffected [7] - Jiangte Electric announced a change in its actual controller to Wang Xin and Zhu Jun, with stock resuming trading on July 29 [8]

Group 1 - The core viewpoint of the article is that AUX Electric Co., Ltd., a leading player in the air conditioning industry, is preparing for a significant IPO on the Hong Kong Stock Exchange after previously submitting its application in January 2025 [1][3] - AUX claims to be the "fifth largest air conditioning supplier globally" and has a history dating back to the 1990s when it adopted aggressive pricing strategies to gain market share [1][4] - The company has achieved nearly 30 billion yuan in annual revenue, although it still lags behind major competitors like Midea and Gree, which reported revenues of 407.2 billion yuan and 190 billion yuan respectively in 2024 [3][4] Group 2 - AUX has expanded its business internationally, reaching over 150 countries and regions, but still faces significant gaps in revenue compared to domestic leaders [3][4] - The competitive landscape has evolved from a focus on high-quality, high-priced products to price wars and diversified competition, with AUX maintaining a strong market presence through innovative strategies [4] - The upcoming IPO represents a potential turning point for AUX, especially following a substantial dividend payout of 3.794 billion yuan prior to its first IPO attempt [3]

Group 1 - UBTECH announced its fifth equity financing since its IPO, aiming to raise approximately HKD 24.73 billion by issuing about 30.16 million new H-shares at HKD 82.00 per share, which is a discount of about 9.14% from the closing price on July 21, 2025 [1] - The total amount raised by UBTECH, including the IPO, has reached HKD 55.82 billion, corresponding to approximately 13.85% of the company's total share capital post-financing [1] Group 2 - GoerTek submitted a prospectus to the Hong Kong Stock Exchange for its subsidiary, GoerTek Microelectronics, aiming for a listing on the main board, marking its second attempt after a previous application lapsed on January 20, 2025 [2] - GoerTek Microelectronics holds a 4.3% market share in the global sensor market, ranking fourth, and a 43.0% share in the acoustic sensor market, ranking first [2] Group 3 - Xiechuang Data announced plans for an IPO in Hong Kong to enhance its international strategy and overseas financing capabilities, focusing on IoT smart terminals and data storage devices [3] - The company, which was listed on the Shenzhen Stock Exchange in July 2020, currently has a market capitalization of approximately RMB 27.51 billion [3] Group 4 - Dongyang Sunshine Pharmaceutical's absorption merger plan was approved with over 99% support at a shareholder meeting, marking a significant step in its listing process, with plans to officially list on August 7 [4] - This merger represents the first case of an H-share absorption merger and privatization listing on the Hong Kong Stock Exchange, avoiding new share issuance while achieving asset integration [4] Group 5 - The Hang Seng Index closed at 25,130.03, with a gain of 0.54% on July 22 [5] - The Hang Seng Tech Index and the National Enterprises Index also saw increases of 0.38% and 0.39%, closing at 5,606.83 and 9,075.60 respectively [5]

Group 1 - Lakala (300773) executed two block trades on July 22, 2025, totaling 200,000 shares with a transaction amount of 4.892 million yuan, at an average price of 24.46 yuan, representing a 12.01% discount to the closing price of 27.80 yuan on that day [1] - The stock price of Lakala showed limited volatility on the same day, opening at 27.72 yuan, reaching a high of 28.15 yuan, a low of 27.69 yuan, and closing at 27.80 yuan, with a trading volume of 1.12 billion yuan and a turnover rate of 5.47% [1] - According to the Q1 report, Lakala's revenue for the quarter was 1.299 billion yuan, a year-on-year decrease of 13.01%, and the net profit attributable to shareholders was 101 million yuan, down 51.71% year-on-year [1] Group 2 - Shareholder reduction actions have continued to attract market attention, with shareholder Sun Haoran reducing holdings by 10.923 million shares from June 19 to July 17, lowering his stake from 8.88% to 7.50%, in line with the reduction plan disclosed in May [1] - Lenovo Holdings plans to reduce its holdings by no more than 23.643 million shares within three months starting from July 23 [1] Group 3 - Lakala has been in the spotlight due to its plans for a Hong Kong stock listing and exploration of stablecoin business, with an announcement on June 16 indicating progress in H-share issuance to apply for a stablecoin license and communication with the Hong Kong Monetary Authority regarding related opportunities [2] - Following this news, Lakala's stock price surged from 23 yuan to 35.97 yuan in mid-June, marking an increase of over 50%, although it has recently retreated amid market adjustments [2]

Core Viewpoint - The article discusses the handling of special shareholder rights in the context of companies applying for listing on the Hong Kong Stock Exchange, emphasizing the need for compliance with the Hong Kong Stock Exchange's regulations and the negotiation dynamics between the listing companies and their investors [4][20]. Summary by Sections Special Shareholder Rights Scope and Principles - The number of domestic companies applying for Hong Kong listings has significantly increased since 2024, leading to the necessity of addressing how special shareholder rights are managed [4]. - Companies must terminate or arrange special rights according to the Hong Kong Stock Exchange's Listing Rules and the new listing applicant guidelines [4][5]. - The handling of these rights is primarily guided by the opinions of overseas lawyers involved in the listing process, although domestic lawyers play a crucial role in drafting related agreements [4][19]. Handling of Special Shareholder Rights - According to the Listing Guidelines, special rights not applicable to all shareholders must be revised or terminated before listing [5]. - Special rights include preemptive rights, buyback rights, and liquidation preferences, which generally need to be terminated before the company submits its listing application [8][9]. - The treatment of these rights is stricter in Hong Kong compared to A-share listings, where certain arrangements can be retained under specific conditions [6][7]. Specific Handling Methods for Common Special Rights - Common special rights and their handling methods include: - Preemptive rights must terminate upon listing [9]. - Buyback rights need to be terminated before the listing application is submitted [9]. - Rights related to board nominations can continue if already appointed before listing [10]. - Financial compensation arrangements must be structured to avoid being linked to the listing price or market value [17][18]. Common Issues Regarding Buyback Rights - Buyback rights are a core special right for investors and must be terminated before the listing application is submitted [11]. - The article discusses the potential for a restoration mechanism for these rights if the listing application is rejected or withdrawn [12][13]. - The duration for re-filing a listing application is typically six months, and investors may negotiate terms to ensure their rights are not indefinitely terminated [13][14]. Impact on Corporate Restructuring - Companies must transition from limited liability to joint-stock companies before applying for a Hong Kong listing, which may involve terminating buyback rights to avoid accounting issues [16]. - The handling of special rights during this restructuring phase is critical to ensure compliance with accounting standards and regulatory requirements [16]. Work Mechanism in Projects - The termination of special shareholder rights is a collaborative effort between domestic and overseas lawyers, with input from accountants and sponsors [19]. - The process involves drafting agreements and negotiating terms to ensure compliance with the Hong Kong Stock Exchange's requirements [19]. Conclusion - Proper management of special shareholder rights is essential for companies seeking to list on the Hong Kong Stock Exchange, balancing compliance with shareholder interests is crucial for successful market entry [20].

Core Viewpoint - Aokai Electric has submitted an updated listing application to the Hong Kong Stock Exchange after previously attempting to list on the A-share market and the Shanghai Stock Exchange, citing strategic advantages for business development in Hong Kong [1][2] Company Overview - Aokai Electric's main products include household air conditioners and central air conditioning systems, with brands such as AUX, Huashuan, and AUFIT. The company holds a 7.1% market share, making it the fifth largest air conditioning provider globally as of mid-2024 [2] - The company has expanded its overseas sales to over 150 countries and regions, employing a dual sales model of OBM and ODM, which has contributed to a significant increase in household air conditioner sales from 4.5 million units in March 2022 to 5.5 million units by March 2025 [2] Financial Performance - Aokai Electric's revenue and net profit have shown substantial growth from 2022 to March 2025, with revenues of 19.528 billion, 24.832 billion, 29.759 billion, and 9.352 billion respectively, and net profits of 1.442 billion, 2.487 billion, 2.910 billion, and 0.925 billion respectively. The gross profit margins remained relatively stable, with a compound annual growth rate of 30% during this period [2] Debt Situation - The company's total current liabilities increased from 11.506 billion at the end of 2022 to 18.252 billion by the end of 2024, with a net debt increase from 3.19 billion to 2.47 billion. By the end of 2024, Aokai Electric's asset-liability ratio reached 84.1%, significantly higher than the industry average of 62.3% for Midea Group [3]

Core Viewpoint - The company, KeFu Medical, is planning to issue H-shares and list on the Hong Kong Stock Exchange to accelerate its global strategy and enhance its overseas business capabilities and brand recognition [1][4]. Group 1: Company Overview - KeFu Medical is a comprehensive personal health management enterprise engaged in the research, production, sales, and service of medical devices, covering five major areas: health monitoring, rehabilitation aids, respiratory support, medical care, and traditional Chinese medicine therapy [3]. - The company's main brand "KeFu" includes sub-brands such as "JianEr Hearing," "JiRui Medical," "BeiBeiJia," "YanBenShu," and "YangLiDe" [3]. Group 2: Financial Performance - In the first quarter of this year, KeFu Medical reported a revenue of approximately 738 million yuan, a year-on-year decrease of 8.59%, and a net profit of about 91.43 million yuan, down 9.68% year-on-year [6]. - The company's revenue from overseas markets was approximately 5.91 million yuan in 2024, accounting for only 1.98% of total revenue, indicating that its overseas business is still in the cultivation stage [4]. Group 3: Strategic Intentions - The decision to list on the Hong Kong Stock Exchange aligns with national policies supporting companies going global and aims to enhance the company's international development [4]. - The company has completed acquisitions of Shanghai Huazhou and Ximan Na, which are expected to strengthen its overseas business resources [5]. - Future overseas acquisitions will focus on companies that can supplement product lines or enhance technological capabilities, as well as those with established distribution networks or brand influence [5].

Core Viewpoint - Jinjiang International Group is preparing for an IPO on the Hong Kong Stock Exchange, aiming to leverage its extensive global presence while addressing significant losses in its overseas operations over the past five years, totaling over 2.3 billion yuan [2][7]. Group 1: Company Overview - Jinjiang International is the largest hotel group in China, with a diverse portfolio of brands including Jinjiang Inn, Lavande, and Vienna, catering to various market segments from budget to mid-range [2]. - The company has expanded its footprint to 55 countries, with a notable presence in France, where it operates 773 hotels, and nearly 400 additional locations across Europe, Asia, the Americas, and Africa [2]. Group 2: Financial Performance - In 2024, Jinjiang's overseas market revenue reached 4.256 billion yuan, accounting for 30.8% of total revenue, with a gross margin of 41.9%, significantly higher than the domestic market [6]. - Despite the high gross margin, the overseas operations have faced continuous losses, accumulating over 300 million euros (approximately 2.35 billion yuan) in losses over five years, primarily due to high operational costs in Europe [7][9]. Group 3: Business Strategy - Jinjiang's business model includes both heavy asset and light asset strategies, with a shift towards a light asset model starting in 2024, focusing on franchising rather than direct ownership [5][8]. - The company plans to utilize funds from its IPO to enhance overseas operations, optimize debt, and invest in digital systems, with 50% of the raised capital earmarked for upgrading overseas business and digital infrastructure [10]. Group 4: Challenges and Future Outlook - The company faces significant challenges in its European operations, including high operational costs and cultural integration issues following large-scale acquisitions, particularly with the Louvre Hotels Group [9][13]. - Jinjiang is now targeting Southeast Asia for expansion, adopting a light asset strategy in collaboration with local partners, aiming to capitalize on the region's growing middle class and tourism industry [12][13]. - The success of Jinjiang's expansion into Southeast Asia will depend on its ability to address past integration challenges and avoid resource dispersion across multiple brands [13][14].

Core Viewpoint - The company JinkoSolar (002459.SZ) is facing detailed inquiries from the China Securities Regulatory Commission (CSRC) regarding its Hong Kong listing, focusing on safety production administrative penalties and pending litigation [1][3] Group 1: Regulatory Inquiries - The CSRC requires JinkoSolar to provide detailed explanations of safety production administrative penalties faced by its subsidiaries, including whether the incidents constitute major violations, the status of fines, and corrective measures taken [3] - The company must disclose any other production safety incidents and confirm if they fall under financing restrictions as per the State Council's regulations [3] - In terms of pending litigation, the CSRC demands a comprehensive update on the progress of lawsuits involving the company and its subsidiaries, assessing their potential impact on the Hong Kong listing [3] Group 2: Company Overview - JinkoSolar is a leading player in the photovoltaic industry, involved in the research, production, and sales of solar photovoltaic silicon wafers, cells, modules, and energy storage systems, as well as the development, construction, and operation of solar power plants [3] - According to the prospectus, JinkoSolar ranks third globally in solar module shipments with a market share of 12.3% in 2024, maintaining a position among the top four for ten consecutive years since 2015, with products distributed across 178 countries and regions [3] Group 3: Financial Challenges - In 2024, the company reported a significant loss of 4.656 billion yuan, with a debt-to-asset ratio of 74.74%, the highest among the four major module manufacturers [4] - The company faces challenges due to changes in U.S. tariff policies affecting its operations in Southeast Asia, particularly impacting its factory in Vietnam [4] - A previously invested 1.244 billion yuan project in the U.S. was sold for 1.57 billion yuan in April 2024, indicating financial strain [4]

Company Dynamics - JinkoSolar Technology (002459.SZ) has received inquiries from the China Securities Regulatory Commission (CSRC) regarding its Hong Kong listing process, focusing on safety production-related administrative penalties and pending litigation [2] - The CSRC requires JinkoSolar to provide detailed explanations about the safety production penalties faced by its subsidiaries, including whether these incidents constitute significant violations, the progress of fines paid, and any corrective measures taken [2] - Additionally, the company must disclose any other production safety incidents and whether they fall under restrictions on financing or other disqualifications for listing as per the State Council's regulations [2] Business Overview - JinkoSolar's main business includes the research, production, and sales of solar photovoltaic silicon wafers, cells, modules, and energy storage systems, as well as the development, construction, and operation of solar power plants [3] - In 2024, JinkoSolar is projected to rank third globally in photovoltaic module shipments, with a market share of 12.3%, maintaining a position among the top four for ten consecutive years since 2015 [3] - The company has a global presence, with products covering 178 countries and regions and 16 overseas sales offices established [3] Financial Challenges - The solar industry is highly competitive, and JinkoSolar faces significant challenges, reporting a net loss of 4.656 billion yuan in 2024, with a debt-to-asset ratio of 74.74%, the highest among the four major module manufacturers [3] - The company's interest-bearing debt ratio is close to 36%, indicating a high level of financial leverage [3] - Changes in U.S. tariff policies affecting Southeast Asian countries have impacted its operations in Vietnam, and a previously invested 1.244 billion yuan project in the U.S. was sold for 1.57 billion yuan in April 2024 [3]